To identify clinical and imaging biomarkers that can predict the new onset of diabetes mellitus (NODM) within 1 year of pancreatic resection.
A retrospective chart review was conducted of 426 non-diabetic patients who underwent a pancreaticoduodenectomy or distal pancreatectomy at the University of Pittsburgh Medical Center between 2006 and 2016. Clinical characteristics and the patient’s diabetic status at 1-year post resection were collected from the EMR. Imaging biomarkers included hepatic and pancreatic fat replacement, pancreatic calcifications, pancreatic duct diameter, pancreatic volume and body composition. Univariate and multivariable analyses were performed to demonstrate any predictive biomarkers of diabetes occurrence within 1 year of pancreatic resection.
135/426 (31.7%) patients developed NODM. The only significant clinical predictor was older age (OR 1.02, 95% CI 1.002–1.039, p = 0.032). Imaging characteristics found to be significant included hepatic steatosis (OR 1.777, 95% CI 1.094–2.886, p = 0.02), larger reduction in pancreas volume (OR 0.989, 95% CI 0.979–0.999, p = 0.027), and greater preoperative visceral fat (OR 1.004, 95% CI 1.001–1.006, p = 0.001).
Age, presence of hepatic steatosis, change in pancreatic volume, and preoperative visceral fat are independent predictive biomarkers for NODM following pancreatic resection.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Teh SH, Diggs BS, Deveney CW, Sheppard BC. Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines. Arch. Surg. 2009;144(8):713-721.
Augustin T, Burstein MD, Schneider EB, et al. Frailty predicts risk of life-threatening complications and mortality after pancreatic resections. Surgery. 2016;160(4):987-996.
Gleeson EM, Shaikh MF, Shewokis PA, et al. WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. Surgery. 2016;160(5):1279-1287.
Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J. Gastrointest. Surg. 2006;10(9):1199-1210; discussion 1210-1191.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81-90.
Scholten L, Mungroop TH, Haijtink SAL, et al. New-onset diabetes after pancreatoduodenectomy: A systematic review and meta-analysis. Surgery. 2018.
Beger HG, Poch B, Mayer B, Siech M. New Onset of Diabetes and Pancreatic Exocrine Insufficiency After Pancreaticoduodenectomy for Benign and Malignant Tumors: A Systematic Review and Meta-analysis of Long-term Results. Ann. Surg. 2018;267(2):259-270.
De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: a systematic review. Ann. Surg. 2015;261(5):854-861.
Burkhart RA, Gerber SM, Tholey RM, et al. Incidence and severity of pancreatogenic diabetes after pancreatic resection. J. Gastrointest. Surg. 2015;19(2):217-225.
Nguyen A, Demirjian A, Yamamoto M, Hollenbach K, Imagawa DK. Development of Postoperative Diabetes Mellitus in Patients Undergoing Distal Pancreatectomy versus Whipple Procedure. Am. Surg. 2017;83(10):1050-1053.
King J, Kazanjian K, Matsumoto J, et al. Distal pancreatectomy: incidence of postoperative diabetes. J. Gastrointest. Surg. 2008;12(9):1548-1553.
Beger HG, Mayer B. Early postoperative and late metabolic morbidity after pancreatic resections: An old and new challenge for surgeons - A review. Am. J. Surg. 2018;216(1):131-134.
Kwon JH, Kim SC, Shim IK, et al. Factors Affecting the Development of Diabetes Mellitus After Pancreatic Resection. Pancreas. 2015;44(8):1296-1303.
Kang JS, Jang JY, Kang MJ, et al. Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors. World J. Surg. 2016;40(2):440-446.
Hirata K, Nakata B, Amano R, Yamazoe S, Kimura K, Hirakawa K. Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients. J. Gastrointest. Surg. 2014;18(9):1597-1603.
Shirakawa S, Matsumoto I, Toyama H, et al. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J. Gastrointest. Surg. 2012;16(12):2212-2219.
Singh AN, Pal S, Kilambi R, et al. Diabetes after pancreaticoduodenectomy: can we predict it? J. Surg. Res. 2018;227:211-219.
Ross R. Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetol. 2003;40 Suppl 1:S45-50.
Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. Journal of applied physiology (Bethesda, Md. : 1985). 2004;97(6):2333-2338.
Elliott IA, Epelboym I, Winner M, Allendorf JD, Haigh PI. Population-Level Incidence and Predictors of Surgically Induced Diabetes and Exocrine Insufficiency after Partial Pancreatic Resection. The Permanente journal. 2017;21.
Sakata N, Egawa S, Rikiyama T, et al. Computed tomography reflected endocrine function of the pancreas. J. Gastrointest. Surg. 2011;15(3):525-532.
Jang M, Park HW, Huh J, et al. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI. Eur. Radiol. 2018.
Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br. J. Surg. 2016;103(4):434-442.
Okumura S, Kaido T, Hamaguchi Y, et al. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Ann. Surg. Oncol. 2017;24(12):3732-3740.
Nagakawa Y, Nakamura Y, Honda G, et al. Learning curve and surgical factors influencing the surgical outcomes during the initial experience with laparoscopic pancreaticoduodenectomy. J. Hepatobiliary Pancreat. Sci. 2018;25(11):498-507.
Yun SP, Seo HI, Kim S, Kim DU, Baek DH. Does the pancreatic volume reduction rate using serial computed tomographic volumetry predict new onset diabetes after pancreaticoduodenectomy? Medicine (Baltimore). 2017;96(13):e6491.
Oh HM, Yoon YS, Han HS, Kim JH, Cho JY, Hwang DW. Risk factors for pancreatogenic diabetes after pancreaticoduodenectomy. Korean journal of hepato-biliary-pancreatic surgery. 2012;16(4):167-171.
Matveyenko AV, Veldhuis JD, Butler PC. Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes. 2006;55(8):2347-2356.
Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
American Diabetes Association. The Staggering Cost of Diabetes. http://www.diabetes.org/diabetes-basics/statistics/infographics/adv-staggering-cost-of-diabetes.html. Accessed December 1, 2018.
Lv X, Qiao W, Leng Y, Wu L, Zhou Y. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis. PLoS One. 2017;12(2):e0171370.
The statistical analysis for this project was supported in part by the National Institutes of Health through Grant Number UL1-TR-001857.
Conflict of interest
All authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Donovan, A.L., Furlan, A., Borhani, A.A. et al. Evaluation of clinical and imaging biomarkers for the prediction of new onset diabetes following pancreatic resection. Abdom Radiol (2021). https://doi.org/10.1007/s00261-020-02943-3
- Computed tomography
- Pancreatic resection
- Hepatic steatosis